Novo Nordisk A/S: all 1,444 studies

Page 2 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• Compassionate Use of Concizumab if You Have HaemophiliaAvailableNCT04921956
• Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa PegolEnrolling by invitationNCT04682145
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRDRecruitingNCT04580420Phase 2
• A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®Enrolling by invitationNCT04574076
• Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)Enrolling by invitationNCT03972345
• A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYNEnrolling by invitationNCT03745924
• Adverse Event Data Collection From External Registries on Nonacog Beta PegolEnrolling by invitationNCT03690336
• An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)Enrolling by invitationNCT01511393
• A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCompletedNCT06340854Phase 3Results posted
• A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight RangeCompletedNCT06041217Phase 3Results posted
• A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseCompletedNCT05891496Phase 3Results posted
• Phase 1b Study of DCR-AUD in Healthy VolunteersCompletedNCT05845398Phase 1Results posted
• A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)CompletedNCT05823948Phase 3Results posted
• A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCompletedNCT05813912Phase 3Results posted
• A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9Active, not recruitingNCT05723835Phase 3Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose WeightCompletedNCT05649137Phase 3Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)CompletedNCT05646706Phase 3Results posted
• A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedNCT05579249Phase 4Results posted
• A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)TerminatedNCT05568225Phase 2Results posted
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy RangeCompletedNCT05564117Phase 3Results posted
• Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 DiabetesCompletedNCT05533632Phase 4Results posted
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)CompletedNCT05514535Phase 3Results posted
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and OverweightCompletedNCT05486065Phase 2Results posted
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesCompletedNCT05478252Phase 3Results posted
• A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia BCompletedNCT05365217Phase 3Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCompletedNCT05352815Phase 3Results posted
• Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial InfarctionCompletedNCT05350969Phase 2Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)CompletedNCT05259033Phase 3Results posted
• A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 DiabetesCompletedNCT05144984Phase 2Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With ObesityCompletedNCT05132088Phase 3Results posted
• Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)CompletedNCT05082116Phase 3Results posted
• Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisCompletedNCT05064735Phase 3Results posted
• Research Study Looking at How Well Semaglutide Works in People Living With Obesity and PrediabetesCompletedNCT05040971Phase 3Results posted
• A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)CompletedNCT05039450Phase 2Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)CompletedNCT05035095Phase 3Results posted
• A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)CompletedNCT05035082Phase 4Results posted
• Study of DCR-AUD in Healthy VolunteersCompletedNCT05021640Phase 1Results posted
• Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal FunctionCompletedNCT05001269Phase 2Results posted
• Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With ObesityCompletedNCT04998136Phase 3Results posted
• A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart DiseaseCompletedNCT04992065Phase 2Results posted
• Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 DiabetesCompletedNCT04982575Phase 2Results posted
• A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.CompletedNCT04970654Phase 3Results posted
• A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With ObesityCompletedNCT04969939Phase 2Results posted
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)CompletedNCT04880850Phase 3Results posted
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)CompletedNCT04865770Phase 3Results posted
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)CompletedNCT04848480Phase 3Results posted
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)CompletedNCT04795531Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityCompletedNCT04788511Phase 3Results posted
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinCompletedNCT04770532Phase 3Results posted
• A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT04767529Phase 2Results posted
• A Study of Belcesiran in Patients With AATLDTerminatedNCT04764448Phase 2Results posted
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedNCT04760626Phase 3Results posted
• Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesCompletedNCT04707469Phase 3Results posted
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.CompletedNCT04626505Phase 2Results posted
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompletedNCT04596631Phase 3Results posted
• Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesCompletedNCT04588259Phase 3Results posted
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCompletedNCT04560998Phase 3Results posted
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedNCT04460885Phase 3Results posted
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.CompletedNCT04251156Phase 3Results posted
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scCompletedNCT04189848Phase 4Results posted
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04143945Phase 2Results posted
• A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCompletedNCT04109547Phase 3Results posted
• A Research Study on How Well Semaglutide Works in Adolescents With Overweight or ObesityCompletedNCT04102189Phase 3Results posted
• Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsActive, not recruitingNCT04083781Phase 3Results posted
• Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsActive, not recruitingNCT04082429Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCompletedNCT04074161Phase 3Results posted
• A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCompletedNCT04017832Phase 3Results posted
• A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04007107Phase 2Results posted
• A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic SteatohepatitisTerminatedNCT04004325Phase 1/2Results posted
• A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 DiabetesCompletedNCT03989232Phase 3Results posted
• A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver DamageCompletedNCT03987451Phase 2Results posted
• A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT03976401Phase 2Results posted
• A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedNCT03951805Phase 2Results posted
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 InhibitionCompletedNCT03926117Phase 2Results posted
• A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin GlargineCompletedNCT03922750Phase 2Results posted
• A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesCompletedNCT03914326Phase 3Results posted
• A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayActive, not recruitingNCT03878446Phase 2Results posted
• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.CompletedNCT03856047Phase 2Results posted
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2CompletedNCT03847909Phase 2Results posted
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT03819153Phase 3Results posted
• Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 DiabetesCompletedNCT03816761Phase 2Results posted
• STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or ObesityCompletedNCT03811574Phase 3Results posted
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)CompletedNCT03811535Phase 3Results posted
• Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With ObesityCompletedNCT03799198Phase 4Results posted
• A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.CompletedNCT03751657Phase 2Results posted
• Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03693430Phase 3Results posted
• A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesCompletedNCT03689374Phase 3Results posted
• A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO StudyCompletedNCT03687827Phase 4Results posted
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationCompletedNCT03684811Phase 1/2Results posted
• Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle ProgramCompletedNCT03611582Phase 3Results posted
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic TrialCompletedNCT03596450Phase 4Results posted
• Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 TrialTerminatedNCT03588741Phase 3Results posted
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityCompletedNCT03574597Phase 3Results posted
• Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityCompletedNCT03552757Phase 3Results posted
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548987Phase 3Results posted
• STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCompletedNCT03548935Phase 3Results posted
• A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia ACompletedNCT03528551Phase 3Results posted
• Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks PeriodCompletedNCT03449342Phase 4Results posted
• Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCompletedNCT03377699Phase 3Results posted
• Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesCompletedNCT03268005Phase 3Results posted

← Novo Nordisk A/S overview and focus areas